We are live on ! Find out more
RNAM

Avidity Biosciences
RNAM

Delisted

RNAM was delisted on the 26th of February, 2026.

Back to rankings

127 hedge funds and large institutions have $872M invested in Avidity Biosciences in 2022 Q3 according to their latest regulatory filings, with 25 funds opening new positions, 43 increasing their positions, 31 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

9,513% more call options, than puts

Call options by funds: $2.31M | Put options by funds: $24K

92% more first-time investments, than exits

New positions opened: 25 | Existing positions closed: 13

39% more repeat investments, than reductions

Existing positions increased: 43 | Existing positions reduced: 31

15% more capital invested

Capital invested by funds: $757M → $872M (+$115M)

10% more funds holding

Funds holding: 115 → 127 (+12)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

2.33% less ownership

Funds ownership: 104.79% → 102.46% (-2.3%)

Holders
127
Holders Change
+12
Holders Change %
+10.43%
% of All Funds
2.19%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
25
Increased
43
Reduced
31
Closed
13
Calls
$2.31M
Puts
$24K
Net Calls
+$2.28M
Net Calls Change
-$1.18M

Top Buyers

Rank Fund Capital Flow
1
CAC
Cowen and Company
New York
+$29.2M
2
APM
Avidity Partners Management
Texas
+$9.94M
3
Goldman Sachs
Goldman Sachs
New York
+$8.33M
4
RI
RTW Investments
New York
+$7.19M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$5.28M

Top Sellers

Rank Fund Capital Flow
1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$51.9M
2
Wellington Management Group
Wellington Management Group
Massachusetts
-$16.6M
3
Alkeon Capital Management
Alkeon Capital Management
New York
-$12.4M
4
GPP
Great Point Partners
Connecticut
-$7.26M
5
Fidelity Investments
Fidelity Investments
Massachusetts
-$6.44M
Name Holding Trade Value Shares
Change 		Change in
Stake
Citadel Advisors
51
Citadel Advisors
Florida
$921K +$332K +17,338 +44%
Wells Fargo
52
Wells Fargo
California
$882K -$545K -28,505 -35%
California State Teachers Retirement System (CalSTRS)
53
California State Teachers Retirement System (CalSTRS)
California
$855K +$31.4K +1,641 +3%
New York State Common Retirement Fund
54
New York State Common Retirement Fund
New York
$812K +$3.16K +165 +0.3%
BNP Paribas Financial Markets
55
BNP Paribas Financial Markets
France
$711K +$833K +43,523 New
HCA
56
Harbor Capital Advisors
Illinois
$691K -$88.9K -4,648 -10%
Millennium Management
57
Millennium Management
New York
$635K +$744K +38,913 New
WP
58
Woodline Partners
California
$622K +$729K +38,088 New
State of Wisconsin Investment Board
59
State of Wisconsin Investment Board
Wisconsin
$591K -$29K -1,516 -4%
GCM
60
Graham Capital Management
Connecticut
$582K +$682K +35,640 New
MCP
61
Mirador Capital Partners
California
$557K -$12.7K -663 -2%
AP
62
AtonRa Partners
Switzerland
$556K -$12K -627 -2%
CS
63
Credit Suisse
Switzerland
$497K +$108K +5,647 +23%
Qube Research & Technologies (QRT)
64
Qube Research & Technologies (QRT)
United Kingdom
$486K +$569K +29,758 New
AA
65
ALPS Advisors
Colorado
$465K -$19.6K -1,022 -3%
UBS Group
66
UBS Group
Switzerland
$455K -$254K -13,258 -32%
NYLIM
67
New York Life Investment Management
New York
$448K +$41.5K +2,170 +9%
MIM
68
MetLife Investment Management
New Jersey
$418K – – –
AIG
69
American International Group
New York
$397K +$27.4K +1,430 +6%
UBS AM
70
UBS AM
Illinois
$387K – – –
Walleye Trading
71
Walleye Trading
New York
$379K +$444K +23,218 New
State Board of Administration of Florida Retirement System
72
State Board of Administration of Florida Retirement System
Florida
$363K – – –
Mirae Asset Global Investments
73
Mirae Asset Global Investments
South Korea
$356K +$186K +9,729 +80%
Two Sigma Investments
74
Two Sigma Investments
New York
$333K +$390K +20,409 New
Mitsubishi UFJ Asset Management
75
Mitsubishi UFJ Asset Management
Japan
$325K +$6.66K +348 +2%
1 2
3
4 5

RNAM Hedge Fund Activity: Q3 2022 in Review

127 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Avidity Biosciences (RNAM) for Q3 2022, worth a combined $872M — up 15% from $757M a quarter earlier.

Buyers outnumbered sellers: 25 funds opened new RNAM positions and 13 closed out — a net gain of 12 holders — while 43 added to existing stakes and 31 trimmed.

The largest buyer was Cowen and Company, adding an estimated $29.2M. The largest seller was T. Rowe Price Associates, cutting an estimated $51.9M.

  • 127 institutional investors held Avidity Biosciences (RNAM) as of Q3 2022, up from 115 in Q2 2022.
  • Funds reported $872M of Avidity Biosciences stock for Q3 2022, up 15% quarter-over-quarter.
  • 25 funds opened new Avidity Biosciences positions in Q3 2022 and 13 closed out, a net change of +12 holders.
  • The largest Avidity Biosciences buyer in Q3 2022 was Cowen and Company, an estimated $29.2M added.
  • The largest Avidity Biosciences seller in Q3 2022 was T. Rowe Price Associates, an estimated $51.9M sold.

Based on aggregated 13F filings for Q3 2022.